BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36176461)

  • 1. Review of
    Sellami A; Réau M; Montes M; Lagarde N
    Front Endocrinol (Lausanne); 2022; 13():986016. PubMed ID: 36176461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
    Sellami A; Montes M; Lagarde N
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational methods on food contact chemicals: Big data and in silico screening on nuclear receptors family.
    Cozzini P; Cavaliere F; Spaggiari G; Morelli G; Riani M
    Chemosphere; 2022 Apr; 292():133422. PubMed ID: 34971624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.
    Matsuzaka Y; Uesawa Y
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening of potentially endocrine-disrupting chemicals against nuclear receptors and its application to identify PPARγ-bound fatty acids.
    Jaladanki CK; He Y; Zhao LN; Maurer-Stroh S; Loo LH; Song H; Fan H
    Arch Toxicol; 2021 Jan; 95(1):355-374. PubMed ID: 32909075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery.
    Pinne M; Raucy JL
    Expert Opin Drug Discov; 2014 Jun; 9(6):669-86. PubMed ID: 24819724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.
    Gozalbes R; Carbajo RJ; Pineda-Lucena A
    Curr Med Chem; 2010; 17(17):1769-94. PubMed ID: 20345344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of in silico methods and computational systems biology to explore endocrine-disrupting chemical binding with nuclear hormone receptors.
    Ruiz P; Sack A; Wampole M; Bobst S; Vracko M
    Chemosphere; 2017 Jul; 178():99-109. PubMed ID: 28319747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
    Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
    PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hits Discovery on the Androgen Receptor: In Silico Approaches to Identify Agonist Compounds.
    Réau M; Lagarde N; Zagury JF; Montes M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31766271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating high-throughput exposure assessment and in vitro screening data to prioritize endocrine-active potential and dietary risks of pesticides and veterinary drug residues in animal products.
    Luo YS; Chiu ZY; Wu KY; Hsu CC
    Food Chem Toxicol; 2023 Mar; 173():113639. PubMed ID: 36708863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
    Chaudhari P; Bari S
    Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing High-Throughput Screening Data, Integrative Toxicological Prioritization Index Score, and Exposure-Activity Ratios for Chemical Prioritization: A Case Study of Endocrine-Active Pesticides in Food Crops.
    Luo YS; Wu TH
    J Agric Food Chem; 2021 Sep; 69(38):11427-11439. PubMed ID: 34524809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Molecular Initiating Events to Develop a Structural Alert Based Screening Workflow for Nuclear Receptor Ligands Associated with Hepatic Steatosis.
    Mellor CL; Steinmetz FP; Cronin MT
    Chem Res Toxicol; 2016 Feb; 29(2):203-12. PubMed ID: 26787004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-throughput, computational system to predict if environmental contaminants can bind to human nuclear receptors.
    Wang X; Zhang X; Xia P; Zhang J; Wang Y; Zhang R; Giesy JP; Shi W; Yu H
    Sci Total Environ; 2017 Jan; 576():609-616. PubMed ID: 27810749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational evaluation of endocrine activity of biocidal active substances.
    Stanojević M; Vračko Grobelšek M; Sollner Dolenc M
    Chemosphere; 2021 Mar; 267():129284. PubMed ID: 33338726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
    McRobb FM; Kufareva I; Abagyan R
    Toxicol Sci; 2014 Sep; 141(1):188-97. PubMed ID: 24928891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.